Evidence map›Paper›PMID 29165327›Full record

ArticleInternational journal of molecular sciences2017

Effects of Dl-3-n-butylphthalide on Cerebral Ischemia Infarction in Rat Model by Mass Spectrometry Imaging.

Run-Zhe Liu, Chao-Xin Fan, Zhi-Lin Zhang, Xin Zhao, Yi Sun, Hui-Hui Liu, Zong-Xiu Nie, Xiao-Ping Pu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Sequential release ofMaterials today. Bio · 2026
    Article
  2. Article
  3. Spatial metabolic analysis of the regulatory effects of DL-3-n-butylphthalide in a cerebral ischemia-reperfusion mouse model.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  4. Butylphthalide inhibits ferroptosis and ameliorates cerebral Ischaemia-Reperfusion injury in rats by activating the Nrf2/HO-1 signalling pathway.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  5. Neurological Applications of Celery (Molecules (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Run-Zhe LiuNational Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China. 1110307320@pku.edu.cn.
Chao-Xin FanNational Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China. fanchaoxin@bjmu.edu.cn.
Zhi-Lin ZhangNational Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China. zhilinzhang@bjmu.edu.cn.
Xin ZhaoNational Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China. zhaoxin2010@bjmu.edu.cn.
Yi SunNational Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China. sunyi@bjmu.edu.cn.ORCID 0000-0001-7043-5251
Hui-Hui LiuKey Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry Chinese Academy of Sciences, Beijing 100190, China. hhliu@iccas.ac.cn.
Zong-Xiu NieKey Laboratory of Analytical Chemistry for Living Biosystems, Institute of Chemistry Chinese Academy of Sciences, Beijing 100190, China. znie@iccas.ac.cn.
Xiao-Ping PuNational Key Research Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, China. 11956170@pku.edu.cn.
Peking University · CNChinese Academy of Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dl-3-n-butylphthalide (NBP) is a drug that is used in the treatment of ischaemic stroke. However, to the best of our knowledge, there are no systematic studies investigating the effects of dl-3-n-butylphtalide on the brain metabolism of small molecules. In this study, we first investigated the effects of dl-3-n-butylphthalide on the spatial distribution of small molecules in the brains of rats with permanent middle cerebral artery occlusion (pMCAO) using matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF-MS) imaging. After pMCAO modelling or a sham operation, rats were given four mg/kg of dl-3-n-butylphthalide through the caudal vein or saline once a day for nine days. The degree of neurological deficit in rats was evaluated using the modified neurological severity score (mNSS). MALDI-TOF-MS imaging was used to observe the content and distribution of small molecules related to metabolism during focal cerebral ischaemia. Multiple reaction monitoring (MRM) mode with liquid chromatography tandem mass spectrometry (LC-MS/MS) was used to verify the results obtained from MALDI-TOF-MS imaging. These small molecules were found to be involved in glucose metabolism, ATP metabolism, the glutamate-glutamine cycle, malate aspartate shuttle, oxidative stress, and inorganic ion homeostasis. Of the 13 metabolites identified by MALDI-TOF-MS imaging, seven compounds, ATP, ADP, AMP, GMP,

Indexed as

Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationAdenosine TriphosphateAnimalsBenzofuransBrain IschemiaCitric AcidDisease Models, AnimalGlucoseInfarctionMetabolic Networks and PathwaysNeuroprotective AgentsPlatelet Aggregation InhibitorsRatsSeverity of Illness Index3-n-butylphthalideAdenosine TriphosphateBenzofuransCitric AcidGlucoseNeuroprotective AgentsPlatelet Aggregation Inhibitorsdl-3-n-butylphthalidematrix-assisted laser desorption time of flight ionization mass spectrometry imaging (MALDI–TOF–MS imaging)metabolitespermanent middle cerebral artery occlusion (pMCAO)

Identifiers

PMID29165327
PMCPMC5713418
OpenAlexW2768837288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.